
AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "AstraZeneca Pharma India Limited marks consistent 33% growth as the Company announces its annual results for FY 2025-2026".
Filed with NSE · · 5 pages · English

AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "AstraZeneca Pharma India Limited marks consistent 33% growth as the Company announces its annual results for FY 2025-2026".
AstraZeneca Pharma India Limited on 6ix
Follow AstraZeneca Pharma India into a list and get an email when it puts out news.
Follow AstraZeneca Pharma India